Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC2 | Q13490 | 8/20 | 0.42 |
| ▸ | XIAP | P98170 | 7/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.30 |
| ▸ | MLNR | O43193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3098422 | 0.87 | BIRC2 (0.41) | BIRC2XIAP | |
| SCHEMBL3103700 | 0.84 | BIRC2 (0.41) | BIRC2XIAPCHRM1 | |
| SCHEMBL3101583 | 0.82 | BIRC2 (0.46) | BIRC2XIAPCHRM1MLNR | |
| SCHEMBL23714232 | 0.82 | BIRC2 (0.46) | BIRC2XIAPCHRM1MLNR | |
| SCHEMBL3097792 | 0.82 | LTA4H (0.30) | — | |
| SCHEMBL11604982 | 0.80 | BIRC2 (0.45) | BIRC2XIAPMLNR | |
| SCHEMBL8733534 | 0.79 | BIRC2 (0.44) | BIRC2XIAPCHRM1 | |
| SCHEMBL27320502 | 0.79 | BIRC2 (0.47) | BIRC2XIAPMLNR | |
| SCHEMBL3101511 | 0.79 | SIGMAR1 (0.33) | CHRM1 | |
| SCHEMBL17906594 | 0.77 | BIRC2 (0.49) | BIRC2XIAPCHRM1MLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2204394-B1 | PROCESS FOR PRODUCTION OF POLYESTER-CONTAINING FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION FOR USE IN THE PROCESS | TOSOH CORP (JP) | 2017-07-12 | — | — | EP | disclosed |
| US-8980965-B2 | Method for producing polyester type flexible polyurethane foam, and catalyst composition to be used therefor | TOSOH CORPORATION (JP) | 2015-03-17 | — | — | US | disclosed |
| US-20100256249-A1 | METHOD FOR PRODUCING POLYESTER TYPE FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION TO BE USED THEREFOR | TOSOH CORPORATION (JP) | 2010-10-07 | — | — | US | disclosed |
| EP-2204394-A1 | PROCESS FOR PRODUCTION OF POLYESTER-CONTAINING FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION FOR USE IN THE PROCESS | Tosoh Corporation (JP) | 2010-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256249-A1 | METHOD FOR PRODUCING POLYESTER TYPE FLEXIBLE POLYURETHANE FOAM, AND CATALYST COMPOSITION TO BE USED THEREFOR | OR51E2, CYP4F11, FFAR3 | BIRC2 2156/4885XIAP 4553/4885CHRM1 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.